Yanniv Dorone
Senior Vice President @ Fall Line Capital
Stanford, United States
Yanniv Dorone is a Series B investor at Fall Line Capital in Stanford focused on Life Science and Therapeutics. Yanniv Dorone is based out of Stanford, California, and is the Senior Vice President of Fall Line Capital and Board of Directors of Ansa Biotechnologies. Yanniv Dorone attended Stanford University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Yanniv Dorone invests in
Stages Yanniv Dorone invests in
Countries Yanniv Dorone invests in
Investment Focus
Industry
- Life Science 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ansa Biotechnologies
|
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerateinnovation in biological research and engineering. | $46.4M / Series B / Oct 01, 2025 |
Co-Investors
Alternative Investment Management
1 deal together
Altitude Life Science Ventures
1 deal together
Black Opal Ventures
1 deal together
Blue Water Life Science Advisors
1 deal together
About Fall Line Capital
Fall Line Capital primarily seeks investment in broadacre farmland and agricultural technologies. The firm engages in purchasing and actively managing farmland throughout the United States, and by investing in technology companies that are strategic to our landholdings. Fall Line Capital's primary goal is to realize untapped productivity infarmland.
Fall Line Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Libby Spalding
Vice President
|
|||
Wade Condrey
Head of Southern Operations
|
|||
|
Yanniv Dorone
Senior Vice President
|
|||
Baptiste Tellier
Director
|
|||
Clay Mitchell
Co-founder & Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yanniv Dorone invest in?
Yanniv Dorone invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Yanniv Dorone last invest?
The most recent investment recorded for Yanniv Dorone closed in Oct 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
